Preparing for the Next Wave of Weight-Loss Drug Adoption
By 2030, we expect nearly one in three US adults will have used a GLP-1 medication such as Ozempic.
Snap Chart
Türkiye’s Net-Zero Transition: Capacity Has Outpaced Conversion
With clean capacity secured, the bottlenecks have become converting demand and integrating systems.
Report
Four Proven Ways to Create Value—Any Value—from a Corporate Spin-Off
Our recent study shows what it takes to make a spin-off succeed.
Brief
Want to Lead in Consumer Products? Adapt to Retailing’s New Reality
How CPGs can get ahead in the next generation of commerce.
Brief